Search Results - "Coons, Eric M."

Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study by Tijani, Aminat, Coons, Eric M., Mizuki, Britta, Dermady, Miranda, Stanilova, Katerina, Casey, Ashley L., Alqudsi, Muhannad, Gastanaduy, Mariella, Elmayan, Ardem, Bamnolker, Adi, Velez, Juan Carlos Q.

“…Background: Evidence supporting venous thromboembolism (VTE) prophylaxis with direct oral anticoagulants (DOACs) in patients with nephrotic syndrome (NS) is…”
Get full text

Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study by Coons, Eric M., Staubes, Britta A., Casey, Ashley L., Elagizi-Youssef, Stephanie A., Mohammed, Alaa E., Sharma, Nikhil, Kline, Elle R.

“…Background Evidence for direct oral anticoagulants (DOACs) in patients with cirrhosis is limited. Few patients with Child-Turcotte-Pugh (CTP) class B and C…”
Get full text

Direct Oral Anticoagulants vs. Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study: SA-PO710 by Stanilova, Katerina, Tijani, Aminat A., Coons, Eric M., Casey, Ashley, Mizuki, Britta, Dermady, Miranda, Bamnolker, Adi, Alqudsi, Muhannad, Velez, Juan Carlos Q.

Get full text

Best practices for supporting and improving pharmacy resident research and quality improvement projects by Murphy, John E., Azad, Aniqa, Barreto, Jason N., Coons, Eric M., Coons, James C., Drury, Anna Sahlstrom, Goodlet, Kellie J., Hennessey, Erin K., Jennings, Douglas, Kane‐Gill, Sandra L., Morbitzer, Kathryn, Pluckrose, Dawn M., Sikand, Harminder, Weant, Kyle A.

“…The 2023 ACCP Research Affairs Committee was charged with developing a commentary to address best practices in pharmacy resident research and quality…”
Get full text